多西紫杉醇
人血清白蛋白
前列腺癌
体内
Zeta电位
纳米颗粒
体外
化学
生物物理学
癌症
材料科学
医学
纳米技术
生物化学
内科学
生物
生物技术
作者
Ebru Ertugen,Ayça Tunçel,Fatma Yurt
标识
DOI:10.1016/j.jddst.2019.101410
摘要
In this study, docetaxel loaded nanoparticles were synthesized and labeled with 131 I for diagnosis and treatment of prostate cancer. Docetaxel (DTX) was loaded onto human serum albumin nanoparticles (HSA) with 50% efficiency. The size of DTX loaded nanoparticles (DTX-HSA) is in the range of 150–160 nm and these nanoparticles have a zeta potential of −27.2 mV. In in vitro drug release assay, 80% of DTX from loaded DTX-HSA nanoparticles was released at pH 7.4 medium, while 93% of DTX was released from DTX-HSA nanoparticles at pH 5.8 medium at the end of 48 h. The data show that HSA nanoparticles might be increasing in chemotherapy effect as a drug delivery system. DTX-HSA nanoparticles were labeled with 131 I via iodogen method. Intracellular uptake experiments of 131 I-DTX-HSA nanoparticles were done on prostate tumor cells (PC-3) and healthy prostate cells (RWPE-1) at 24 h. In conclusion, 131 I-DTX-HSA appears as suitable agent that might be used in both nuclear imaging and radiotherapy of prostate cancer. In this study, the nuclear imaging potential of 131 I-DTX-HSA was determined as in vitro . The results of this study are important to investigate this potential with in vivo studies in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI